Iteos Therapeutics Inc.

12/12/2024 | Press release | Distributed by Public on 12/12/2024 07:55

iTeos Therapeutics Presents Interim A2A-005 Clinical Trial Data, Translational, and Preclinical Data from Inupadenant at ESMO Immuno-Oncology Congress

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.